Strata Skin Sciences Profit Margin 2010-2024 | SSKN
Current and historical gross margin, operating margin and net profit margin for Strata Skin Sciences (SSKN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Strata Skin Sciences net profit margin as of September 30, 2024 is -28.72%.
| Strata Skin Sciences Annual Profit Margins |
|---|
| Strata Skin Sciences Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.013B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.855B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.039B | 179.00 |
| Inspire Medical Systems (INSP) | United States | $5.776B | 180.15 |
| Enovis (ENOV) | United States | $2.727B | 18.49 |
| IRhythm Technologies (IRTC) | United States | $2.722B | 0.00 |
| Privia Health (PRVA) | United States | $2.578B | 214.80 |
| Omnicell (OMCL) | United States | $2.158B | 70.59 |
| Azenta (AZTA) | United States | $2.106B | 112.71 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.744B | 0.00 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Phreesia (PHR) | United States | $1.215B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.701B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Talkspace (TALK) | United States | $0.578B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.546B | 94.60 |
| Health Catalyst (HCAT) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 78.04 |
| Pulmonx (LUNG) | United States | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.223B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.109B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |